Work

Management of Infusion-Related Reactions Following Daratumumab Monotherapy in Patients with at Least 3 Lines of Prior Therapy or Double Refractory Multiple Myeloma (MM): 54767414MMY2002 (Sirius)

Year: 2015

Type: article

Source: Blood

DOI: 10.1182/blood.v126.23.1829.1829

Authors: Peter M. Voorhees, Brendan Weiss, Saad Usmani, Huaibao Feng, Clarissa Uhlar, Imran Khan, Tahamtan Ahmadi, Sagar Lonial

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Abramson Cancer Center, University of Pennsylvania, Carolinas Healthcare System, Levine Cancer Institute, Janssen Research & Development (United States), Emory University, Winship Cancer Institute

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2548395679

FWCI: 2.268

Cites:

Cited by: 15

Related to: 10